• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz

    Patient Enrollment Ends in Biosense Webster's SmartfIRE Study

    New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device

    Former FDA Director Joins Greenleaf Health

    Alexander D’Amico Named Chief Financial Officer at CytoSorbents
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    Johari Digital Healthcare Ltd.

    NDH Medical Inc.

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    Johari Digital Healthcare Ltd.

    NDH Medical Inc.

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Editorial

    In Pursuit of Device Safety or a Call for Whistleblowers?

    ...

    In Pursuit of Device Safety or a Call for Whistleblowers?
    Implementing a revised reporting system that reduces the burden put on hospitals would improve the current system and ultimately enhance patient safety.
    Sean Fenske, Editor03.07.17
    Late last year, Jeffrey Shuren, M.D., J.D., the U.S. Food and Drug Administration’s (FDA) director of the Center for Devices and Radiological Health, penned a blog for the FDA Voice (http://bit.ly/mpo031750) regarding the coordination between the FDA and hospitals to collect data on medical devices. While a process is already in place to enable hospitals and doctors to report information on a medical device to the manufacturer and/or FDA when it is responsible for an adverse event, there is no check in place to ensure this is happening. Unfortunately, based on a review of 17 hospitals by the FDA, it appears not to be occurring in a significant number of instances.

    In December 2015, the FDA initiated inspections on 17 hospitals due to incidents related to morcellators (tied to the spread of uterine cancer) and duodenoscopes (associated with the spread of infections). Neither event generated a corresponding adverse event report within the agency’s MAUDE (manufacturer and user facility device experience) database. According to Shuren, the FDA did, however, gain valuable insight into a number of challenges regarding medical device incident reporting. These included:

    • There is a significant lack of reporting by hospitals to the FDA and/or manufacturers overall. Some healthcare facilities even lack the procedure for this reporting to take place.
    • Hospital staff has not been properly trained to report device incidents.
    • A new system to enable better lines of communication between the hospital and the FDA is required.
    While device safety is the ultimate goal of any such reporting system, there is one aspect of Shuren’s message that did give me pause—does the agency have a possible ulterior motive for improving the reporting system? In his FDA Voice blog, Shuren stated, “At the time of premarket evaluation, however, it is not feasible to identify all possible risks or to have absolute certainty regarding a technology’s benefit-risk profile. Among other reasons, studies required to do so would likely be prohibitively large in order to capture less frequent and more unpredictable effects or consequences. In addition, such larger studies still may not reflect the true benefit-risk profile of the device. Once a device is on the market, for example, doctors may use it beyond the FDA cleared intended use. In addition, subsequent modifications to the device or changes in how the device is used in practice can result in new safety risks or greater frequency of known risks.”

    Sure, off-label use is a problem and manufacturers should be made aware of any such use of their device. If it hasn’t been cleared for a therapy for which it is being used, it could certainly create a headache for the manufacturer, even if they aren’t found to be promoting such use. Might a revised reporting system not only review events where a device may have caused an injury or death, but also be used to seek out off-label use of medical devices in the healthcare environment? Of course, depending upon with whom you speak, a system that looks for such use cases would not necessarily be a bad thing. If the result of such a review simply leads to a penalty against the manufacturer, then I don’t see it as a positive; however, if the review could be used to potentially better position the manufacturer to seek clearance for the off-label use with the FDA, that would ultimately be a benefit—an extension of real-world data collection, if you will.

    Ultimately, a revision to the current reporting system would likely be welcomed by all stakeholders. Putting in place a solution that reduces the burden on hospital personnel to conduct the reporting would alleviate the need for training on the system and proper procedures being put in place. The manufacturer could be made aware of a potential flaw in a device and enable them to address it before the problem becomes more widespread. The FDA would gain more information on medical devices already on the market, enhancing their postmarket surveillance efficiency.

    One tool that might be leveraged to accomplish this would be electronic health records (EHRs) and the data provided from them. If an algorithm could be created to comb through EHRs to seek adverse events that might be tied to medical devices, great value could be gained. What’s done with this information will then be the next challenge to be solved. Does the manufacturer face a penalty or would the system be used to truly enhance the quality of care that’s being delivered with the information being effectively utilized by both device maker and FDA?

    Let’s first fix the reporting system and then that next challenge can be addressed.
    Related Searches
    • fda
    • voice
    • first
    • quality
    Related Knowledge Center
    • Diagnostics
    • Cardiovascular
    • Digital Health
    • Neurological
    • Testing
    • Surgical
    • Patient Monitoring
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    RedDress’ ActiGraft System Receives New FDA Clearance RedDress’ ActiGraft System Receives New FDA Clearance
    FDA Warns of Possible False Positives for Abbott COVID-19 Lab Tests FDA Warns of Possible False Positives for Abbott COVID-19 Lab Tests
    FDA Clears Inova Diagnostics FDA Clears Inova Diagnostics' Digital Multi-Analyte System
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Vicarious Surgical Business Combination with D8 Holdings Approved Vicarious Surgical Business Combination with D8 Holdings Approved
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Siemens Healthineers’ Somatom X.ceed Tomography Scanner Cleared by FDA Siemens Healthineers’ Somatom X.ceed Tomography Scanner Cleared by FDA
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Thermo Fisher Scientific Launches Updated COVID-19 Test Thermo Fisher Scientific Launches Updated COVID-19 Test

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21


    • First CellFX Procedure Performed in Canada

      First CellFX Procedure Performed in Canada

      Pulse Biosciences expands its controlled launch of the CellFX System into the country.
      Business Wire 09.22.21

    • RedDress’ ActiGraft System Receives New FDA Clearance

      RedDress’ ActiGraft System Receives New FDA Clearance

      ActiGraft Ver.02 System is intended for the safe and rapid POC preparation of an in-vitro blood clot.
      Globe Newswire 09.22.21

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Zeus Introduces Absorv XSE Oriented Tubing
    • Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    • Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz
    • Patient Enrollment Ends in Biosense Webster's SmartfIRE Study
    • New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    Tim Knavish Elected PPG Chairman and CEO
    Alabama Students Gain Real-World Experience with Internships at BASF
    AkzoNobel Names Sweet Embrace as Interpon Color of the Year 2024
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz
    Patient Enrollment Ends in Biosense Webster's SmartfIRE Study
    New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
    WuXi Vaccines Launches Vaccines CDMO Site in China
    MilliporeSigma Launches Integrated mRNA Services
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    BASF and StitchCrew Introduce Educational Bootcamp for Indigenous Beauty Brands
    Top 10 Most Popular Fashion Designer Makeup Brands—According to Landys Chemist
    Jennifer Coolidge Collaborates with e.l.f. Cosmetics for 'Dirty Pillows' Lip Collection
    Happi

    Latest Breaking News From Happi

    Victoria Beckham Beauty to Make Fragrance Debut with Unisex Scent Trio
    Bio-Oil Launches 'Labor of Love' Campaign
    Wharton To Honor Leonard A. Lauder with Retail Excellence Award
    Ink World

    Latest Breaking News From Ink World

    Sapphire Ink – SB Eco Series Receives Oeko-Tex Eco Passport ZDHC Level 3 Certification
    Flint Group Digital with Xeikon Present at FEFCO Technical Seminar
    R.E. Carroll Inc. Packs, Donates 400 Backpacks to Students
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Schreiner MediPharm introduces Freeze-Light-Protect syringe label
    Kodak launches PRINERGY 10.0
    UPM Raflatac receives new approval for linerless label printing
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ana Fraisse Joins The American Cleaning Institute
    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Intech Acquires Lenkbar LLC
    ONWARD Completes First-in-Human for ARC-IM to Restore Upper Extremity Function
    Michael S. Aronow Installed as AOFAS President
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    PPG and Flō-Optics Enter Exclusive Supplier Agreement
    SEMI North America Advisory Board Adds New Members
    Nhat Tin Logistics Enhances Operations with Zebra Technologies

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login